STAAR Surgical (STAA)
(Delayed Data from NSDQ)
$46.39 USD
-0.38 (-0.81%)
Updated Apr 19, 2024 04:00 PM ET
After-Market: $46.39 0.00 (0.00%) 6:38 PM ET
3-Hold of 5 3
D Value B Growth B Momentum C VGM
Price, Consensus and EPS Surprise
STAA 46.39 -0.38(-0.81%)
Will STAA be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for STAA based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for STAA
Strength Seen in Staar Surgical (STAA): Can Its 16.5% Jump Turn into More Strength?
Strength Seen in West Pharmaceutical (WST): Can Its 5.7% Jump Turn into More Strength?
STAA: What are Zacks experts saying now?
Zacks Private Portfolio Services
Staar Surgical (STAA) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
Staar Surgical (STAA) Beats Q4 Earnings Estimates
Merit Medical (MMSI) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Other News for STAA
Apple To $210? Here Are 10 Top Analyst Forecasts For Thursday
Staar Surgical price target raised by $8 at Mizuho, here's why
Staar Surgical Co's Meteoric Rise: Unpacking the 52% Surge in Just 3 Months
Analysts Offer Insights on Healthcare Companies: Staar Surgical (STAA), Ocugen (OCGN) and Moderna (MRNA)
Staar Surgical price target raised by $14 at Canaccord, here's why